Yovel Oren S, Ben Eliahu Shmuel, Kleinmann Guy
Department of Ophthalmology, Kaplan Medical Center, 1 Pasternak Road, Rehovot, 76100, Israel.
Curr Drug Deliv. 2016;13(1):90-4. doi: 10.2174/1567201812666150901094810.
To investigate postoperative endophthalmitis (POE) prevention by moxifloxacin prophylaxis.
After crystalline lens removal and intraocular lens (IOL) implantation, 18 rabbit eyes were injected intracameral with different coagulase negative staphylococci (CNS) inoculums in order to determine the minimum inoculum required for a reproducible POE model. Another 28 similar eyes were divided into Group A, which was implanted with standard IOLs with intracameral injection of 100 μg/0.1 ml moxifloxacin, Group B implanted with moxifloxacin presoaked IOLs, Group C treated as Groups A and B, and Group D (control) implanted with standard IOLs only. At the end of surgery, all eyes were injected with the minimal inoculum that had developed POE, and treated with topical moxifloxacin for 24 hours. They were then evaluated using 3 different POE scores.
The minimum CNS concentration that developed reproducible POE was 5x10(5) CFUs/0.1 ml. Scores: 1. Clinical endophthalmitis was judged in 5/7 (71%), 4/7 (57%), 2/7 (28%) and 7/7 (100%) of Groups A-D eyes, respectively, p=0.005 and 0.057 for Groups B and C compared to D, respectively. 2. Endophthalmitis Scores for Groups A-D were 14.5±6.8, 10.6±4.5, 12.0±3.9 and 18.6±1.7, respectively, p=0.015, and ~0.07 for Groups B and C compared to D, respectively. 3. Hypoyon was noted in 2/6 (33%), 2/7 (28%), 2/7 and 6/7 (86%) of the Group A-D eyes, respectively, p=0.053, 0.03 and 0.03 for Groups A-C compared to D, respectively.
POE can be best prevented by prophylactic moxifloxacin by presoaked IOLs treatment.
研究莫西沙星预防术后眼内炎(POE)的效果。
在摘除晶状体并植入人工晶状体(IOL)后,向18只兔眼房内注射不同浓度的凝固酶阴性葡萄球菌(CNS)接种物,以确定可重复的POE模型所需的最小接种量。另外28只相似的眼睛分为A组,植入标准IOL并房内注射100μg/0.1ml莫西沙星;B组植入预先用莫西沙星浸泡的IOL;C组的处理同A组和B组;D组(对照组)仅植入标准IOL。手术结束时,向所有眼睛注射已引发POE的最小接种量,并局部使用莫西沙星治疗24小时。然后使用3种不同的POE评分进行评估。
可重复引发POE的最小CNS浓度为5×10⁵CFU/0.1ml。评分:1. A-D组眼中分别有5/7(71%)、4/7(57%)、2/7(28%)和7/7(100%)被判定为临床眼内炎,B组和C组与D组相比,p值分别为0.005和0.057。2. A-D组的眼内炎评分为14.5±6.8、10.6±4.5、12.0±3.9和18.6±1.7,B组和C组与D组相比,p值分别为0.015和~0.07。3. A-D组眼中分别有2/6(33%)、2/7(28%)、2/7和6/7(86%)出现前房积脓,A-C组与D组相比,p值分别为0.053、0.03和0.03。
通过预先用莫西沙星浸泡IOL进行预防性治疗,能最佳地预防POE。